| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Summit Therapeutics Inc. | Chief Financial Officer | Common Stock | 355K | $1.33M | $3.75 | Mar 26, 2024 | By Dhingra Family Revocable Trust |
| ILLUMINA, INC. | SVP, Chief Financial Officer | Common Stock | 8.83K | $1.13M | $127.75 | May 6, 2024 | Direct |
| CareDx, Inc. | Chief Financial Officer | Common Stock | 33.1K | $396K | $11.94 | Mar 25, 2022 | Direct |
| CareDx, Inc. | Chief Financial Officer | Common Stock | 5K | $59.7K | $11.94 | Mar 25, 2022 | By Dhingra Family Revocable Trust |
| ILLUMINA, INC. | SVP, Chief Financial Officer | Performance Shares | 10.3K | May 6, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| GRAL | GRAIL, LLC | Jun 11, 2024 | 0 | $0 | 3 | Jun 12, 2024 | Director |
| ILMN | ILLUMINA, INC. | May 6, 2024 | 3 | $0 | 4 | May 8, 2024 | SVP, Chief Financial Officer |
| ILMN | ILLUMINA, INC. | Apr 15, 2024 | 0 | $0 | 3 | Apr 24, 2024 | SVP, Chief Financial Officer |
| SMMT | Summit Therapeutics Inc. | Mar 26, 2024 | 1 | $375K | 4 | Mar 27, 2024 | Chief Financial Officer |
| SMMT | Summit Therapeutics Inc. | Dec 13, 2023 | 2 | $44.3K | 4 | Dec 13, 2023 | Chief Financial Officer |
| SMMT | Summit Therapeutics Inc. | Mar 7, 2023 | 1 | $206K | 4 | Mar 8, 2023 | Chief Financial Officer |
| SMMT | Summit Therapeutics Inc. | Aug 16, 2022 | 2 | $36.6K | 4/A | Mar 8, 2023 | Chief Financial Officer |
| SMMT | Summit Therapeutics Inc. | May 31, 2022 | 0 | $0 | 3 | Jun 2, 2022 | Chief Financial Officer |
| SMMT | Summit Therapeutics Inc. | May 31, 2022 | 1 | $0 | 4 | Jun 2, 2022 | Chief Financial Officer |
| CDNA | CareDx, Inc. | Mar 25, 2022 | 1 | -$47.5K | 4 | Mar 28, 2022 | Chief Financial Officer |
| CDNA | CareDx, Inc. | Feb 2, 2022 | 2 | $0 | 4 | Feb 4, 2022 | Chief Financial Officer |
| CDNA | CareDx, Inc. | Nov 24, 2021 | 1 | $212K | 4 | Nov 29, 2021 | Chief Financial Officer |